The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 21, 2020

Filed:

Dec. 05, 2017
Applicant:

Porex Technologies Corporation, Colonial Heights, VA (US);

Inventors:

Chandrasiri Jayakody, St. Charles, MI (US);

Anthony J. Joles, St. Charles, MI (US);

Ramesh Srinivasan, St. Charles, MI (US);

Geoffrey M. Stoltz, St. Charles, MI (US);

Assignee:

POREX TECHNOLOGIES CORPORATION, Colonial Heights, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 15/44 (2006.01); A61L 15/42 (2006.01); A61L 15/46 (2006.01); C08J 9/00 (2006.01); A61L 15/60 (2006.01); B29K 75/00 (2006.01); B29K 105/04 (2006.01); B29K 105/16 (2006.01); B29K 505/14 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61L 15/44 (2013.01); A61L 15/425 (2013.01); A61L 15/46 (2013.01); A61L 15/60 (2013.01); C08J 9/008 (2013.01); A61L 2300/104 (2013.01); A61L 2300/206 (2013.01); A61L 2300/404 (2013.01); A61L 2400/12 (2013.01); B29K 2075/00 (2013.01); B29K 2105/04 (2013.01); B29K 2105/162 (2013.01); B29K 2505/14 (2013.01); B29L 2031/753 (2013.01); C08J 2375/04 (2013.01); C08J 2375/06 (2013.01); C08J 2375/08 (2013.01);
Abstract

An absorbent wound dressing comprises a hydrophilic porous substrate and polymer-stabilized silver nanoparticles distributed throughout the porous substrate. The silver nanoparticles have a particle size din the range of about 45 nm to about 85 nm and the silver nanoparticles are present in the substrate in an amount of about 0.16% to about 1.5% by weight of the total weight of the substrate. The wound dressing produces a 7-day log reduction of 4 or more for bacteria in accordance with the Modified AATCC Test Method 100. The wound dressing is also non-cytotoxic in accordance with ISO 10993-5 standard procedure for medical device cytotoxicity assessment.


Find Patent Forward Citations

Loading…